JT Pharmaceuticals logo — Harnessing the power of peptides for innovative pain managem...

JT Pharmaceuticals

Harnessing the power of peptides for innovative pain management solutions

Founded 2014 Biotechnology

General Information

Company Name JT Pharmaceuticals
Founded Year 2014
Industries Biotechnology
Social

Get notified when JT Pharmaceuticals moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About JT Pharmaceuticals

JT Pharmaceuticals is a biotechnology startup founded in 2014, focusing on innovative pain management solutions through the utilization of peptides. With the slogan "Harnessing the power of peptides for innovative pain management solutions," the company is dedicated to developing pain management medications and peptide-based therapies. Utilizing a proprietary peptide modification process, JT Pharmaceuticals aims to create novel pharmaceuticals from bioactive peptides. This distinctive approach offers several advantages, including more predictable and shorter development cycles, exclusive patents for peptide compounds, and a fertile ground for innovation. JT Pharmaceuticals operates in the biotechnology industry, positioning itself at the intersection of healthcare and technology. While the specific location of the company's headquarters is not provided, the startup prides itself on being at the forefront of advancements in pain management and pharmaceutical development. As of the latest available information, details on the last investment and investors are not disclosed. Nonetheless, JT Pharmaceuticals' focus on harnessing the potential of peptides for cutting-edge pain management solutions presents an opportunity for potential investors seeking to tap into the biotechnology sector's potential for impactful innovation and healthcare advancements.

Taxonomy: pharmaceuticals, pain management, peptide-based therapies, bioactive peptides, patented process, innovation, drug development, medical research, proprietary technology

No funding data available for JT Pharmaceuticals yet.

Get notified when JT Pharmaceuticals raises funding

JT Pharmaceuticals Alternatives & Competitors

JT Pharmaceuticals vs

Leader in Peptide Research. ELISA kits, Antibodies, Custom Peptide Synthesis.

16 employees
Biotechnology, Health Care
JT Pharmaceuticals vs

Innovative therapies for stress, mood, and behavior disorders

Series Unknown
5 employees
Biotechnology, Health Care
JT Pharmaceuticals vs

Innovative oncology care safeguarding against chemotherapy-induced intestinal mucositis.

Series A
Biotechnology, Health Care

FAQ About JT Pharmaceuticals

Harnessing the power of peptides for innovative pain management solutions
JT Pharmaceuticals was founded in 2014.
JT Pharmaceuticals operates in the following industries: Biotechnology.
Top alternatives and competitors to JT Pharmaceuticals include Phoenix Pharmaceuticals, Inc., Azevan Pharmaceuticals, GLyPharma Therapeutic, Ecovatec Solutions Inc., Galmed Pharmaceuticals Ltd.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
JT Pharmaceuticals and Phoenix Pharmaceuticals, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors JT Pharmaceuticals and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy